in this issue
Markets :: Fine Chemicals/Biotech :: Agricultural chemicals
Syngenta's first-half growth held back by North America; outlook confirmed
July 23, 2014 | Natasha Alperowicz
Syngenta’s net income including restructuring and impairment was $1.4 billion, 1% lower in the first six months of this year, on sales up 1%, to $8.5 billion, the company announced today. Earnings per share, excluding restructuring and impairment, were 2% lower, at $15.60. The late start to North American season reduced crop protection use, but the company grew strongly in all other regions with price increases across the business. Ebitda was 3% lower in reported terms but increased by 6% at constant exchange rates. The Ebitda margin was 26.6% compared with...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee